nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—GRIN2B—bipolar disorder	0.246	0.311	CbGaD
Haloperidol—DRD4—bipolar disorder	0.145	0.183	CbGaD
Haloperidol—DRD3—bipolar disorder	0.125	0.158	CbGaD
Haloperidol—DRD1—bipolar disorder	0.122	0.155	CbGaD
Haloperidol—DRD2—bipolar disorder	0.0863	0.109	CbGaD
Haloperidol—HTR2A—bipolar disorder	0.0667	0.0844	CbGaD
Haloperidol—GRIN2B—telencephalic ventricle—bipolar disorder	0.00651	0.0927	CbGeAlD
Haloperidol—DRD3—telencephalic ventricle—bipolar disorder	0.00546	0.0777	CbGeAlD
Haloperidol—DRD1—telencephalic ventricle—bipolar disorder	0.00391	0.0556	CbGeAlD
Haloperidol—HTR2A—locus ceruleus—bipolar disorder	0.00321	0.0457	CbGeAlD
Haloperidol—HTR1B—telencephalic ventricle—bipolar disorder	0.00317	0.0451	CbGeAlD
Haloperidol—HTR1D—telencephalic ventricle—bipolar disorder	0.00307	0.0436	CbGeAlD
Haloperidol—DRD2—telencephalic ventricle—bipolar disorder	0.00231	0.0329	CbGeAlD
Haloperidol—CYP2C19—urine—bipolar disorder	0.00218	0.031	CbGeAlD
Haloperidol—CYP1A2—urine—bipolar disorder	0.00178	0.0253	CbGeAlD
Haloperidol—HTR2A—autonomic nervous system—bipolar disorder	0.00171	0.0243	CbGeAlD
Haloperidol—CYP2C9—urine—bipolar disorder	0.00169	0.024	CbGeAlD
Haloperidol—HTR2A—telencephalic ventricle—bipolar disorder	0.00152	0.0217	CbGeAlD
Haloperidol—HTR2A—urine—bipolar disorder	0.00139	0.0198	CbGeAlD
Haloperidol—CYP3A4—urine—bipolar disorder	0.00129	0.0183	CbGeAlD
Haloperidol—CYP2D6—urine—bipolar disorder	0.00127	0.018	CbGeAlD
Haloperidol—CBR1—adrenal cortex—bipolar disorder	0.00117	0.0166	CbGeAlD
Haloperidol—CYP2C19—blood plasma—bipolar disorder	0.00114	0.0162	CbGeAlD
Haloperidol—H1F0—adrenal cortex—bipolar disorder	0.000958	0.0136	CbGeAlD
Haloperidol—CYP1A2—blood plasma—bipolar disorder	0.000929	0.0132	CbGeAlD
Haloperidol—GRIN2B—nervous system—bipolar disorder	0.000923	0.0131	CbGeAlD
Haloperidol—CYP3A5—blood plasma—bipolar disorder	0.000896	0.0127	CbGeAlD
Haloperidol—CYP2C9—blood plasma—bipolar disorder	0.000881	0.0125	CbGeAlD
Haloperidol—GRIN2B—cerebellum—bipolar disorder	0.000869	0.0124	CbGeAlD
Haloperidol—DRD4—brain—bipolar disorder	0.000841	0.012	CbGeAlD
Haloperidol—CBR1—thyroid gland—bipolar disorder	0.000814	0.0116	CbGeAlD
Haloperidol—DRD3—nervous system—bipolar disorder	0.000774	0.011	CbGeAlD
Haloperidol—HTR2A—blood plasma—bipolar disorder	0.000726	0.0103	CbGeAlD
Haloperidol—GRIN2B—brain—bipolar disorder	0.000706	0.01	CbGeAlD
Haloperidol—SIGMAR1—adrenal cortex—bipolar disorder	0.000692	0.00985	CbGeAlD
Haloperidol—HTR2B—adrenal cortex—bipolar disorder	0.00069	0.00982	CbGeAlD
Haloperidol—CBR1—nervous system—bipolar disorder	0.000685	0.00975	CbGeAlD
Haloperidol—CYP3A4—blood plasma—bipolar disorder	0.000672	0.00957	CbGeAlD
Haloperidol—H1F0—thyroid gland—bipolar disorder	0.000667	0.0095	CbGeAlD
Haloperidol—CYP2D6—blood plasma—bipolar disorder	0.000661	0.00941	CbGeAlD
Haloperidol—Loperamide—POMC—bipolar disorder	0.000655	0.103	CrCbGaD
Haloperidol—CBR1—cerebellum—bipolar disorder	0.000644	0.00917	CbGeAlD
Haloperidol—Moclobemide—MAOA—bipolar disorder	0.000625	0.0988	CrCbGaD
Haloperidol—DRD3—brain—bipolar disorder	0.000591	0.00842	CbGeAlD
Haloperidol—H1F0—nervous system—bipolar disorder	0.000561	0.00799	CbGeAlD
Haloperidol—DRD1—nervous system—bipolar disorder	0.000554	0.00789	CbGeAlD
Haloperidol—H1F0—cerebellum—bipolar disorder	0.000528	0.00752	CbGeAlD
Haloperidol—CBR1—brain—bipolar disorder	0.000523	0.00745	CbGeAlD
Haloperidol—Sertindole—DRD4—bipolar disorder	0.000509	0.0805	CrCbGaD
Haloperidol—SIGMAR1—thyroid gland—bipolar disorder	0.000482	0.00686	CbGeAlD
Haloperidol—HTR2B—thyroid gland—bipolar disorder	0.000481	0.00684	CbGeAlD
Haloperidol—ABCB1—blood plasma—bipolar disorder	0.000476	0.00677	CbGeAlD
Haloperidol—Droperidol—DRD2—bipolar disorder	0.000472	0.0745	CrCbGaD
Haloperidol—HTR1B—nervous system—bipolar disorder	0.000449	0.00639	CbGeAlD
Haloperidol—Sertindole—DRD3—bipolar disorder	0.000439	0.0694	CrCbGaD
Haloperidol—HTR1D—nervous system—bipolar disorder	0.000435	0.00619	CbGeAlD
Haloperidol—H1F0—brain—bipolar disorder	0.000429	0.0061	CbGeAlD
Haloperidol—DRD1—brain—bipolar disorder	0.000424	0.00603	CbGeAlD
Haloperidol—Mazindol—SLC6A3—bipolar disorder	0.000409	0.0646	CrCbGaD
Haloperidol—HTR2B—nervous system—bipolar disorder	0.000404	0.00576	CbGeAlD
Haloperidol—SIGMAR1—cerebellum—bipolar disorder	0.000381	0.00543	CbGeAlD
Haloperidol—Sertindole—HTR2C—bipolar disorder	0.000369	0.0583	CrCbGaD
Haloperidol—Droperidol—HTR2A—bipolar disorder	0.000364	0.0576	CrCbGaD
Haloperidol—Sertindole—HTR1A—bipolar disorder	0.000358	0.0566	CrCbGaD
Haloperidol—HTR1B—brain—bipolar disorder	0.000343	0.00488	CbGeAlD
Haloperidol—HTR1D—brain—bipolar disorder	0.000332	0.00473	CbGeAlD
Haloperidol—CYP1A2—thyroid gland—bipolar disorder	0.000328	0.00467	CbGeAlD
Haloperidol—DRD2—nervous system—bipolar disorder	0.000327	0.00466	CbGeAlD
Haloperidol—CYP1A1—thyroid gland—bipolar disorder	0.000324	0.00461	CbGeAlD
Haloperidol—KCNH2—nervous system—bipolar disorder	0.000323	0.00459	CbGeAlD
Haloperidol—SIGMAR1—brain—bipolar disorder	0.00031	0.00441	CbGeAlD
Haloperidol—HTR2B—brain—bipolar disorder	0.000309	0.0044	CbGeAlD
Haloperidol—DRD2—cerebellum—bipolar disorder	0.000308	0.00438	CbGeAlD
Haloperidol—Mazindol—SLC6A4—bipolar disorder	0.000306	0.0483	CrCbGaD
Haloperidol—Sertindole—SLC6A4—bipolar disorder	0.000306	0.0483	CrCbGaD
Haloperidol—Sertindole—DRD2—bipolar disorder	0.000304	0.048	CrCbGaD
Haloperidol—KCNH2—cerebellum—bipolar disorder	0.000304	0.00432	CbGeAlD
Haloperidol—Fluspirilene—HTR1A—bipolar disorder	0.000292	0.0461	CrCbGaD
Haloperidol—CYP1A1—nervous system—bipolar disorder	0.000272	0.00388	CbGeAlD
Haloperidol—HRH1—nervous system—bipolar disorder	0.000259	0.00368	CbGeAlD
Haloperidol—DRD2—brain—bipolar disorder	0.00025	0.00356	CbGeAlD
Haloperidol—Fluspirilene—SLC6A4—bipolar disorder	0.000249	0.0394	CrCbGaD
Haloperidol—Fluspirilene—DRD2—bipolar disorder	0.000248	0.0391	CrCbGaD
Haloperidol—KCNH2—brain—bipolar disorder	0.000247	0.00351	CbGeAlD
Haloperidol—ABCB1—adrenal cortex—bipolar disorder	0.000242	0.00344	CbGeAlD
Haloperidol—Sertindole—HTR2A—bipolar disorder	0.000235	0.0371	CrCbGaD
Haloperidol—HTR2A—nervous system—bipolar disorder	0.000216	0.00307	CbGeAlD
Haloperidol—CYP1A1—brain—bipolar disorder	0.000208	0.00296	CbGeAlD
Haloperidol—HTR2A—cerebellum—bipolar disorder	0.000203	0.00289	CbGeAlD
Haloperidol—CYP3A4—nervous system—bipolar disorder	0.0002	0.00285	CbGeAlD
Haloperidol—HRH1—brain—bipolar disorder	0.000198	0.00281	CbGeAlD
Haloperidol—CYP2D6—nervous system—bipolar disorder	0.000197	0.0028	CbGeAlD
Haloperidol—Fluspirilene—HTR2A—bipolar disorder	0.000191	0.0302	CrCbGaD
Haloperidol—CYP2D6—cerebellum—bipolar disorder	0.000185	0.00263	CbGeAlD
Haloperidol—ABCB1—thyroid gland—bipolar disorder	0.000168	0.00239	CbGeAlD
Haloperidol—HTR2A—brain—bipolar disorder	0.000165	0.00235	CbGeAlD
Haloperidol—CYP2D6—brain—bipolar disorder	0.00015	0.00214	CbGeAlD
Haloperidol—ABCB1—nervous system—bipolar disorder	0.000141	0.00201	CbGeAlD
Haloperidol—ABCB1—cerebellum—bipolar disorder	0.000133	0.0019	CbGeAlD
Haloperidol—ABCB1—brain—bipolar disorder	0.000108	0.00154	CbGeAlD
Haloperidol—CYP3A5—Metabolism—TSHB—bipolar disorder	9.46e-06	7.13e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—CACNB2—bipolar disorder	9.46e-06	7.13e-05	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—COMT—bipolar disorder	9.43e-06	7.1e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—POMC—bipolar disorder	9.41e-06	7.08e-05	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—MAOA—bipolar disorder	9.37e-06	7.05e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—NTRK1—bipolar disorder	9.34e-06	7.03e-05	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—POMC—bipolar disorder	9.33e-06	7.02e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—DPYD—bipolar disorder	9.31e-06	7.01e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—ADCY2—bipolar disorder	9.26e-06	6.97e-05	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—POMC—bipolar disorder	9.2e-06	6.93e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—CLOCK—bipolar disorder	9.18e-06	6.91e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—NTRK1—bipolar disorder	9.14e-06	6.88e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—S100B—bipolar disorder	9.08e-06	6.83e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—ADCY2—bipolar disorder	9.04e-06	6.81e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—IMPA1—bipolar disorder	9.01e-06	6.78e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TCF7L2—bipolar disorder	9.01e-06	6.78e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—NTRK1—bipolar disorder	9e-06	6.77e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—POMC—bipolar disorder	8.98e-06	6.76e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—DRD2—bipolar disorder	8.95e-06	6.74e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—TPH2—bipolar disorder	8.94e-06	6.73e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—TSHB—bipolar disorder	8.94e-06	6.73e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—CACNB2—bipolar disorder	8.94e-06	6.73e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—ADCY2—bipolar disorder	8.92e-06	6.72e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—S100B—bipolar disorder	8.89e-06	6.69e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TCF7L2—bipolar disorder	8.89e-06	6.69e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—DRD2—bipolar disorder	8.83e-06	6.65e-05	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—HTR2A—bipolar disorder	8.82e-06	6.64e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—DPYD—bipolar disorder	8.8e-06	6.62e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—S100B—bipolar disorder	8.75e-06	6.59e-05	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—HTR2A—bipolar disorder	8.66e-06	6.52e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—CACNA1C—bipolar disorder	8.66e-06	6.52e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—NR1D1—bipolar disorder	8.64e-06	6.5e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—NTRK1—bipolar disorder	8.59e-06	6.47e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—POMC—bipolar disorder	8.47e-06	6.38e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PIK3C2A—bipolar disorder	8.44e-06	6.35e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—POMC—bipolar disorder	8.36e-06	6.29e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—S100B—bipolar disorder	8.35e-06	6.29e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—NCAN—bipolar disorder	8.26e-06	6.22e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—CACNA1C—bipolar disorder	8.18e-06	6.16e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NTRK1—bipolar disorder	8.1e-06	6.1e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—SLC5A3—bipolar disorder	8.09e-06	6.09e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—NRG1—bipolar disorder	8.01e-06	6.03e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—HTR2A—bipolar disorder	8.01e-06	6.03e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NTRK1—bipolar disorder	7.99e-06	6.02e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—HTR1A—bipolar disorder	7.99e-06	6.01e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PIK3C2A—bipolar disorder	7.97e-06	6e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—COMT—bipolar disorder	7.93e-06	5.97e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—MAOA—bipolar disorder	7.88e-06	5.93e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—S100B—bipolar disorder	7.87e-06	5.93e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TAC1—bipolar disorder	7.86e-06	5.92e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	7.86e-06	5.92e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—HTR2A—bipolar disorder	7.86e-06	5.92e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—HTR1A—bipolar disorder	7.86e-06	5.92e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—NRG1—bipolar disorder	7.85e-06	5.91e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—HTR1A—bipolar disorder	7.84e-06	5.9e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—S100B—bipolar disorder	7.77e-06	5.85e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TAC1—bipolar disorder	7.74e-06	5.83e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TAC1—bipolar disorder	7.72e-06	5.81e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—NRG1—bipolar disorder	7.72e-06	5.81e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—DRD1—bipolar disorder	7.71e-06	5.81e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—HTR2C—bipolar disorder	7.71e-06	5.81e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—NDUFV2—bipolar disorder	7.66e-06	5.77e-05	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—MTHFR—bipolar disorder	7.62e-06	5.74e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—DRD1—bipolar disorder	7.59e-06	5.71e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—HTR2C—bipolar disorder	7.59e-06	5.71e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—HTR2C—bipolar disorder	7.57e-06	5.7e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—DRD1—bipolar disorder	7.57e-06	5.7e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—SNAP25—bipolar disorder	7.57e-06	5.7e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CLOCK—bipolar disorder	7.51e-06	5.65e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NTRK2—bipolar disorder	7.5e-06	5.65e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—DRD3—bipolar disorder	7.47e-06	5.62e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—GSK3A—bipolar disorder	7.44e-06	5.6e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—AKR1C4—bipolar disorder	7.42e-06	5.59e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NTRK2—bipolar disorder	7.38e-06	5.56e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—NRG1—bipolar disorder	7.37e-06	5.55e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NTRK2—bipolar disorder	7.37e-06	5.55e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—DRD3—bipolar disorder	7.35e-06	5.53e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—DRD3—bipolar disorder	7.33e-06	5.52e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CLOCK—bipolar disorder	7.33e-06	5.52e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—GSK3A—bipolar disorder	7.32e-06	5.51e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CACNB2—bipolar disorder	7.32e-06	5.51e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—TSHB—bipolar disorder	7.32e-06	5.51e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—TPH2—bipolar disorder	7.32e-06	5.51e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—GSK3A—bipolar disorder	7.3e-06	5.5e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—DRD4—bipolar disorder	7.25e-06	5.46e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—HTR2A—bipolar disorder	7.22e-06	5.44e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—DPYD—bipolar disorder	7.2e-06	5.42e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—SNAP25—bipolar disorder	7.15e-06	5.38e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—TPH2—bipolar disorder	7.14e-06	5.38e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—TSHB—bipolar disorder	7.14e-06	5.38e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CACNB2—bipolar disorder	7.14e-06	5.38e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—DRD4—bipolar disorder	7.13e-06	5.37e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—DRD4—bipolar disorder	7.12e-06	5.36e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—HTR2A—bipolar disorder	7.07e-06	5.33e-05	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—POMC—bipolar disorder	7.04e-06	5.3e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—DPYD—bipolar disorder	7.03e-06	5.29e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—HTR2A—bipolar disorder	6.96e-06	5.24e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NRG1—bipolar disorder	6.95e-06	5.23e-05	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—POMC—bipolar disorder	6.93e-06	5.22e-05	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—POMC—bipolar disorder	6.92e-06	5.21e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CLOCK—bipolar disorder	6.91e-06	5.2e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NRG1—bipolar disorder	6.86e-06	5.16e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CLOCK—bipolar disorder	6.85e-06	5.15e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—ADCY2—bipolar disorder	6.83e-06	5.14e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TCF7L2—bipolar disorder	6.8e-06	5.12e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—TPH2—bipolar disorder	6.73e-06	5.07e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—TSHB—bipolar disorder	6.73e-06	5.07e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CACNB2—bipolar disorder	6.73e-06	5.07e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—ADCY2—bipolar disorder	6.72e-06	5.06e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—ADCY2—bipolar disorder	6.7e-06	5.05e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—ADCY2—bipolar disorder	6.7e-06	5.04e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TCF7L2—bipolar disorder	6.69e-06	5.04e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CACNA1C—bipolar disorder	6.69e-06	5.04e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TCF7L2—bipolar disorder	6.68e-06	5.03e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—TPH2—bipolar disorder	6.67e-06	5.02e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CACNB2—bipolar disorder	6.67e-06	5.02e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—TSHB—bipolar disorder	6.67e-06	5.02e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—NR1D1—bipolar disorder	6.66e-06	5.02e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—DRD2—bipolar disorder	6.65e-06	5e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—HTR2A—bipolar disorder	6.64e-06	5e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—DRD2—bipolar disorder	6.63e-06	4.99e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—DPYD—bipolar disorder	6.62e-06	4.98e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—DPYD—bipolar disorder	6.56e-06	4.94e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CACNA1C—bipolar disorder	6.53e-06	4.92e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PIK3C2A—bipolar disorder	6.52e-06	4.91e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	6.43e-06	4.84e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—MTHFR—bipolar disorder	6.41e-06	4.83e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—POMC—bipolar disorder	6.4e-06	4.82e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—NCAN—bipolar disorder	6.37e-06	4.8e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PIK3C2A—bipolar disorder	6.37e-06	4.79e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—ADCY2—bipolar disorder	6.33e-06	4.76e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—POMC—bipolar disorder	6.29e-06	4.74e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—POMC—bipolar disorder	6.28e-06	4.73e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—HTR2A—bipolar disorder	6.27e-06	4.72e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—SLC5A3—bipolar disorder	6.25e-06	4.7e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—HTR2A—bipolar disorder	6.18e-06	4.65e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CACNA1C—bipolar disorder	6.16e-06	4.63e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NTRK1—bipolar disorder	6.12e-06	4.6e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CACNA1C—bipolar disorder	6.1e-06	4.59e-05	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—POMC—bipolar disorder	6.1e-06	4.59e-05	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—INS—bipolar disorder	6.06e-06	4.56e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NTRK1—bipolar disorder	6.02e-06	4.53e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NTRK1—bipolar disorder	6e-06	4.52e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	6e-06	4.52e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	5.95e-06	4.48e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—S100B—bipolar disorder	5.95e-06	4.48e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	5.87e-06	4.42e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CLOCK—bipolar disorder	5.85e-06	4.4e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—S100B—bipolar disorder	5.85e-06	4.4e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—SNAP25—bipolar disorder	5.85e-06	4.4e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—S100B—bipolar disorder	5.84e-06	4.39e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—GSK3B—bipolar disorder	5.82e-06	4.38e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—POMC—bipolar disorder	5.77e-06	4.34e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—INS—bipolar disorder	5.74e-06	4.32e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—COMT—bipolar disorder	5.73e-06	4.32e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—SNAP25—bipolar disorder	5.71e-06	4.3e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—TPH2—bipolar disorder	5.7e-06	4.29e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CACNB2—bipolar disorder	5.7e-06	4.29e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—TSHB—bipolar disorder	5.7e-06	4.29e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—GSK3B—bipolar disorder	5.69e-06	4.29e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—MAOA—bipolar disorder	5.69e-06	4.29e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—POMC—bipolar disorder	5.65e-06	4.25e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—INS—bipolar disorder	5.62e-06	4.23e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—DPYD—bipolar disorder	5.61e-06	4.22e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—GSK3B—bipolar disorder	5.6e-06	4.22e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—POMC—bipolar disorder	5.56e-06	4.19e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—INS—bipolar disorder	5.53e-06	4.16e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—COMT—bipolar disorder	5.42e-06	4.08e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—SNAP25—bipolar disorder	5.38e-06	4.05e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—MAOA—bipolar disorder	5.38e-06	4.05e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—GSK3B—bipolar disorder	5.35e-06	4.03e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—SNAP25—bipolar disorder	5.33e-06	4.02e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—POMC—bipolar disorder	5.31e-06	4e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—INS—bipolar disorder	5.28e-06	3.97e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NRG1—bipolar disorder	5.25e-06	3.95e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CACNA1C—bipolar disorder	5.21e-06	3.93e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ADCY2—bipolar disorder	5.18e-06	3.9e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NRG1—bipolar disorder	5.16e-06	3.89e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NRG1—bipolar disorder	5.15e-06	3.88e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—POMC—bipolar disorder	5.13e-06	3.86e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—INS—bipolar disorder	5.1e-06	3.84e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	5.08e-06	3.83e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ADCY2—bipolar disorder	5.05e-06	3.8e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—GSK3B—bipolar disorder	5.04e-06	3.8e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	5.01e-06	3.77e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—POMC—bipolar disorder	5e-06	3.77e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—GSK3B—bipolar disorder	4.98e-06	3.75e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—INS—bipolar disorder	4.98e-06	3.75e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—POMC—bipolar disorder	4.94e-06	3.72e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—INS—bipolar disorder	4.91e-06	3.7e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ADCY2—bipolar disorder	4.76e-06	3.58e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—HTR2A—bipolar disorder	4.73e-06	3.56e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ADCY2—bipolar disorder	4.72e-06	3.55e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—HTR2A—bipolar disorder	4.65e-06	3.5e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—MTHFR—bipolar disorder	4.63e-06	3.49e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—SNAP25—bipolar disorder	4.56e-06	3.43e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CLOCK—bipolar disorder	4.52e-06	3.4e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—COMT—bipolar disorder	4.43e-06	3.34e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—MAOA—bipolar disorder	4.4e-06	3.31e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—TSHB—bipolar disorder	4.4e-06	3.31e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—TPH2—bipolar disorder	4.4e-06	3.31e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CACNB2—bipolar disorder	4.4e-06	3.31e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—MTHFR—bipolar disorder	4.38e-06	3.3e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—DPYD—bipolar disorder	4.33e-06	3.26e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—COMT—bipolar disorder	4.33e-06	3.26e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—MAOA—bipolar disorder	4.3e-06	3.23e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—COMT—bipolar disorder	4.08e-06	3.07e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—MAOA—bipolar disorder	4.05e-06	3.05e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—COMT—bipolar disorder	4.04e-06	3.04e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ADCY2—bipolar disorder	4.03e-06	3.04e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CACNA1C—bipolar disorder	4.02e-06	3.03e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—MAOA—bipolar disorder	4.01e-06	3.02e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	3.92e-06	2.95e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—GSK3B—bipolar disorder	3.81e-06	2.87e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—POMC—bipolar disorder	3.78e-06	2.84e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—INS—bipolar disorder	3.76e-06	2.83e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—GSK3B—bipolar disorder	3.75e-06	2.82e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—GSK3B—bipolar disorder	3.74e-06	2.82e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—POMC—bipolar disorder	3.72e-06	2.8e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—POMC—bipolar disorder	3.71e-06	2.79e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—POMC—bipolar disorder	3.71e-06	2.79e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—INS—bipolar disorder	3.7e-06	2.78e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—INS—bipolar disorder	3.69e-06	2.78e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—INS—bipolar disorder	3.69e-06	2.78e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—MTHFR—bipolar disorder	3.58e-06	2.7e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—SNAP25—bipolar disorder	3.52e-06	2.65e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—POMC—bipolar disorder	3.5e-06	2.64e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—MTHFR—bipolar disorder	3.5e-06	2.63e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—INS—bipolar disorder	3.48e-06	2.62e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—COMT—bipolar disorder	3.45e-06	2.6e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—MAOA—bipolar disorder	3.43e-06	2.58e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—MTHFR—bipolar disorder	3.3e-06	2.48e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—MTHFR—bipolar disorder	3.27e-06	2.46e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ADCY2—bipolar disorder	3.11e-06	2.34e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—POMC—bipolar disorder	2.87e-06	2.16e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—INS—bipolar disorder	2.85e-06	2.15e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—POMC—bipolar disorder	2.8e-06	2.11e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—MTHFR—bipolar disorder	2.79e-06	2.1e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—INS—bipolar disorder	2.78e-06	2.09e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—COMT—bipolar disorder	2.67e-06	2.01e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—MAOA—bipolar disorder	2.65e-06	1.99e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—POMC—bipolar disorder	2.64e-06	1.98e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—INS—bipolar disorder	2.62e-06	1.97e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—POMC—bipolar disorder	2.61e-06	1.97e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—INS—bipolar disorder	2.6e-06	1.96e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—POMC—bipolar disorder	2.23e-06	1.68e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—INS—bipolar disorder	2.22e-06	1.67e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—MTHFR—bipolar disorder	2.15e-06	1.62e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—POMC—bipolar disorder	1.72e-06	1.3e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—INS—bipolar disorder	1.71e-06	1.29e-05	CbGpPWpGaD
